Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China

Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world's second-largest economy, where the appetite for similar treatments is surging.